ProgrammableMarketing/altoslabs.com (opens in a new tab)
PDF

Views

  • Plan
  • Roadmap
  • Research

On this page

  • The brief
  • Start here
  • Idea portfolio
  • Effort vs impact
  • This week · 6
  • This quarter · 9
  • Big bets · 3
  • Wildcards · 3
  • How we can help
Generated Oct 23, 2026
  1. Programmable
  2. Playbooks
  3. Altos Labs
Altos Labs logo

growth playbook · Oct 23, 2026

altoslabs.com (opens in a new tab)

Altos Labs growth playbook

Diagnosis

Altos Labs is a privately funded research company with sites in the Bay Area, San Diego and Cambridge, UK, and its hiring shows a turn toward development: a CRO and KOL Alliances manager to build an outsourced research network, a project leader for work through clinical trials, in vivo fibrosis models, new IP leaders, and Institute of Computation leaders for ML and the lab-in-the-loop.

For a company at this stage, growth means winning the best scientists and partners. The website lags: no partnering page, no publications, undated news without recent milestones, and no pages for the institutes.

This playbook adds a partner front door, publications and institute pages first, then builds the CRO and KOL programs, faster contracting and IP review, and longer-term investigator networks and open benchmarks.

Growth Score

6/10

Biggest Opportunity

Use the website and the new alliances role together so top CROs, opinion leaders and scientists come to Altos, not only the other way round.

Biggest Risk

Peers such as NewLimit, Retro Biosciences, Life Biosciences and Calico compete for the same scientists and partners, and silence about progress lets their stories lead.

01

Start here

The three moves to make first. Each one is written up in full below.

  1. 1

    Give CROs and opinion leaders a front door: a "Partner with Altos" page for the new alliances manager

    Draft the page from the role's vetting criteria and publish it with a simple intake form.

    High impact First result in 1 month
  2. 2

    Publish a publications page with every Altos paper

    Export the list of Altos-affiliated papers from PubMed.

    High impact First result in 1 month
  3. 3

    Date the Featured page and add what is missing: the Dorian acquisition and the Forbes ranking

    Add dates to the existing items.

    Medium impact First result in 2 weeks

02

Your idea portfolio

21 ideas, grouped by when to run them. Open any idea for how to run it: the steps, who to approach, copy you can use, and how to measure it.

  • 6 ideas are marked Unexpected: plays you are unlikely to have tried.

Every idea placed by the effort it takes against the impact it could have. Quick wins sit top left; select a number to open that idea. The filters below narrow the list by status, timing, category and what Programmable can build.

Effort vs impactEach number is an idea. Select one to open it.
Impact →
Quick wins · 3Big bets · 8Fill-ins · 9Reconsider · 1
Effort →

Showing 21 of 21 ideas

This week 6

Quick wins with a clear first action.

  • 01

    Altos is hiring a CRO and KOL Alliances manager to scout, vet and onboard contract research organizations and key opinion leaders, and to run "a significant outsourced research program". But altoslabs.com has no partnering page at all: the 51-page site offers only info@ and media@ email addresses, and nothing tells a CRO what Altos outsources or how it qualifies partners. Peers such as Calico have a public partnering page.

    High impactLow effort First result in 1 month Senior Manager/Manager

    First action

    Draft the page from the role's vetting criteria and publish it with a simple intake form.

    How to measure it

    Qualified CRO and KOL submissions

    Now
    –
    Target
    30 a quarter
    By
    90 days

    Steps

    1. 1

      Agree the scope

      Study types Altos will consider outsourcing and what stays in-house.

      Senior Manager/Manager, CRO and KOL Alliances 2 days

    2. 2

      Write the criteria

      Quality, capacity, turnaround, compliance and IP terms, from the vetting framework.

      Senior Manager/Manager, CRO and KOL Alliances 2 days

    3. 3

      Legal review

      Confidentiality wording; no confidential information in the form.

      Deputy General Counsel and VP, Intellectual Property 3 days

    4. 4

      Build the form

      Capability statement, therapeutic and model areas, certifications.

      Web team 2 days

    5. 5

      Route and triage

      Submissions to the alliances manager with a weekly review.

      Business and Laboratory Operations Manager, 3DS 1 day

    6. 6

      Link it

      Contact page, footer and the alliances job post.

      Web team 1 hour

    7. 7

      Measure

      Submissions, qualified share and time to first study.

      Senior Manager/Manager, CRO and KOL Alliances monthly

    First result
    1 month
    Cost
    Staff time only
    Owner
    Senior Manager/Manager, CRO and KOL Alliances

    Smallest test

    Publish a one-paragraph partnering note with an email alias this week.

    Why it works

    Publish a short "Partner with Altos" page: the study types Altos outsources (large-animal models, disease model optimization, GLP and non-GLP studies), the qualification criteria from the new vetting framework (quality, capacity, turnaround, GLP/GCP/IACUC compliance, IP protection), and an intake form that routes CRO capability statements and KOL interest to the alliances manager. Add a separate line for academic collaborations, and link it from the contact page and footer.

    The alliances manager starts with a qualified inbound pipeline instead of cold scouting, CROs self-select against stated criteria, and opinion leaders see a clear way to engage. It also signals to the field that Altos is moving toward development.

    Ready to use

    ChecklistPartner with Altos page

    [ ] Study types outsourced
    [ ] Qualification criteria (quality, capacity, turnaround, GLP/GCP/IACUC, IP)
    [ ] Intake form, non-confidential only
    [ ] Separate KOL and academic route
    [ ] Linked from contact page and footer
    [ ] Weekly triage owner
    [ ] Monthly report on qualified submissions

    Risks and how to handle them

    • Unsolicited volume

      Ask for specific capabilities and reply with a standard note.

    • Confidential details sent by partners

      Tell submitters to share only non-confidential information until an NDA is signed.

    Evidence

    • HiringSenior Manager/Manager, CRO and KOL Alliances (contract to hire, posted September 21, 2026, San Diego): will "lead the identification, qualification, and ongoing management of our external R&D ecosystem", "scouting, vetting, and managing top-tier Contract Research Organizations (CROs) and Key Opinion Leaders (KOLs) across global biopharma, academia, and specialized research institutes", "securing and overseeing a significant outsourced research program", and "Lead the onboarding, governance, and strategic direction of KOL networks" across "translational, clinical, and regulatory pathways".Source
    • HiringThe same role names where outsourcing adds value ("large-animal models, disease model optimization, GLP/non-GLP studies"), asks for "rigorous vetting frameworks for CROs" (scientific rigor, quality, capacity, turnaround times, compliance such as GCP, GLP, IACUC and IP protection), and study designs with "clear go/no-go criteria".Source
    • Your websiteSitemap (51 URLs, read October 22, 2026): home, about, science, careers, contact, FAQ, legal pages, four Featured items (newest last modified August 2025) and 39 team profiles. There is no page for publications, partnering, the institutes, or the pipeline.Source
    • Your websiteContact page: a street address for the Bay Area site only, phone numbers for San Diego and Cambridge, UK, and two email addresses, info@ and media@. There is no form or route for research partners, CROs, clinicians or patients.Source
    • Competitor researchPeers' own sites: Calico links to /publications and /partnering pages; Life Biosciences has a publications page and a pipeline page; NewLimit is "extending human healthspan by unlocking regenerative potential"; Retro Biosciences "develops therapies that target aging biology to extend healthy human lifespan by 10 years".Source
  • 02

    The Cell paper on mesenchymal drift was described as one of the first major peer-reviewed reports from Altos investigators, yet the site lists no papers. Calico and Life Biosciences both keep publications pages. Scientists, KOLs and CROs judge a research company by its papers first.

    High impactLow effort First result in 1 month Communications lead

    First action

    Export the list of Altos-affiliated papers from PubMed.

    How to measure it

    Publication page visits

    Now
    –
    Target
    2,000 a month
    By
    90 days

    Steps

    1. 1

      Collect papers

      PubMed and bioRxiv by affiliation.

      Communications lead 2 days

    2. 2

      Write summaries

      Two lines each.

      Communications lead 1 week

    3. 3

      Build the page

      Filters by institute and topic.

      Web team 3 days

    4. 4

      Link profiles

      Papers on team pages.

      Web team 2 days

    5. 5

      Set a process

      Add papers on publication.

      Communications lead ongoing

    6. 6

      Measure

      Visits and referrals to careers.

      Web team monthly

    First result
    1 month
    Cost
    Staff time only
    Owner
    Communications lead

    Smallest test

    Publish the ten most cited papers.

    Why it works

    Add a publications page listing every peer-reviewed paper and preprint with Altos authors, filterable by institute and topic, each with a two-line plain summary. Link papers from the team profiles.

    Papers are the strongest credential for recruiting scientists and opinion leaders, and a list makes them findable in search and AI answers.

    Risks and how to handle them

    • Incomplete lists

      Ask each lab to confirm its papers.

    Evidence

    • News coverage"Inhibition of mesenchymal drift as a strategy for rejuvenation", published in Cell in 2025, was described by Genetic Engineering & Biotechnology News as one of the first major peer-reviewed reports from Altos Labs investigators; it reports widespread upregulation of mesenchymal genes across human tissues with age and disease. The site has no list of Altos papers.Source
    • Competitor researchPeers' own sites: Calico links to /publications and /partnering pages; Life Biosciences has a publications page and a pipeline page; NewLimit is "extending human healthspan by unlocking regenerative potential"; Retro Biosciences "develops therapies that target aging biology to extend healthy human lifespan by 10 years".Source
    • Your websiteSitemap (51 URLs, read October 22, 2026): home, about, science, careers, contact, FAQ, legal pages, four Featured items (newest last modified August 2025) and 39 team profiles. There is no page for publications, partnering, the institutes, or the pipeline.Source
    • HiringInstitute of Computation hiring: a Director / Senior Director, Machine Learning for Biology ("Altos is asking questions biology has no method for yet"), a Director / Senior Director, Lab-in-the-Loop ("The rate limit on ML for biology is rarely the model. It is the loop between what the lab measures and what the model needs"), a Senior Scientist, Machine Learning, and a contract Senior Knowledge Engineer who will own "a large canonical LinkML/Biolink schema including REST/MCP/CLI service layer" and "an agentic / human-in-the-loop curation framework".Source
  • 03

    The Featured page has no dates and its newest item dates from August 2025. The Dorian Therapeutics acquisition and the Forbes 2026 Best Startups ranking, which every job post quotes, are not on the site.

    Medium impactLow effort First result in 2 weeks Communications lead

    First action

    Add dates to the existing items.

    How to measure it

    Updates published

    Now
    –
    Target
    3 a quarter
    By
    2 quarters

    Steps

    1. 1

      Add dates

      All items.

      Web team 1 hour

    2. 2

      Write updates

      Dorian, papers, Forbes.

      Communications lead 1 week

    3. 3

      Calendar

      Monthly.

      Communications lead monthly

    4. 4

      Share

      LinkedIn and X.

      Communications lead ongoing

    5. 5

      Archive

      Older media pieces in a list.

      Web team 1 day

    6. 6

      Measure

      Visits and shares.

      Web team monthly

    First result
    2 weeks
    Cost
    $0
    Owner
    Communications lead

    Smallest test

    Post the Forbes recognition this week.

    Why it works

    Add dates to every item, publish short updates for the Dorian acquisition, key papers and awards, and add the Forbes recognition. Commit to at least one update a month.

    Dated, current news shows momentum to candidates, partners and press.

    Risks and how to handle them

    • Sensitive news

      Run each update past legal.

    Evidence

    • Your websiteThe Featured page carries no dates. Its items are the appointment of Joan Mannick, M.D., as Chief Medical Officer and Head of Product Development, the launch of the Institute of Computation, a BBVA Frontiers of Knowledge Award to a Distinguished Investigator, and older media pieces (Inverse, The Economist, Endpoints News) about the company's launch.Source
    • News coverageIn May 2025 Altos acquired Dorian Therapeutics, a Stanford spinout developing small-molecule "senoblockers", with preclinical programs in lung fibrosis and osteoarthritis. The acquisition does not appear on altoslabs.com.Source
    • HiringEvery Altos job post: "Altos Labs has been named one of the Top 3 Biotech Companies and ranked for the second year on the Forbes 2026 Best Startups in America list"; this recognition is not on the website's Featured page.Source
    • Your websiteSitemap (51 URLs, read October 22, 2026): home, about, science, careers, contact, FAQ, legal pages, four Featured items (newest last modified August 2025) and 39 team profiles. There is no page for publications, partnering, the institutes, or the pipeline.Source
  • 04

    The FAQ has five questions and still describes "initial funding"; several meta descriptions call Altos "a new life science company". Candidates, partners and journalists now ask about the pipeline, clinical plans, the institutes and how to partner.

    Medium impactLow effort First result in 2 weeks Communications lead

    First action

    List the ten most common questions to info@ and media@.

    How to measure it

    Generic emails to info@

    Now
    –
    Target
    -30%
    By
    90 days

    Steps

    1. 1

      Collect questions

      From inboxes.

      Communications lead 2 days

    2. 2

      Write answers

      Factual, reviewed.

      Communications lead 3 days

    3. 3

      Legal review

      No forward-looking claims.

      Deputy General Counsel and VP, Intellectual Property 2 days

    4. 4

      Publish

      With FAQ markup.

      Web team 1 day

    5. 5

      Update metas

      All pages.

      Web team 1 day

    6. 6

      Review

      Twice a year.

      Communications lead 6 months

    First result
    2 weeks
    Cost
    $0
    Owner
    Communications lead

    Smallest test

    Add three questions this week.

    Why it works

    Expand the FAQ to cover the institutes, how Altos works with partners, how to apply and what the hiring process is, where the science stands (without forward-looking claims), and media contacts. Refresh old meta descriptions.

    Clear answers reduce repetitive emails and shape how search engines and AI assistants describe Altos.

    Risks and how to handle them

    • Disclosure risk

      Keep science answers general.

    Evidence

    • Your websiteFAQ: five questions (what Altos does, locations, founders, whether it is public, investors). The investor answer says Altos "raised initial funding from renowned company builders and investors, including ARCH Venture Partners"; several meta descriptions still call Altos "a new life science company".Source
    • Your websiteAbout page: Altos "merges the best of academia and industry"; it is "developing multi-scale generative models to unravel the language of cell health" and is "generating a significant volume of high-quality data internally while also integrating external data sets"; the Institute of Computation complements "the Institutes of Science and the Institute of Medicine".Source
    • Your websiteContact page: a street address for the Bay Area site only, phone numbers for San Diego and Cambridge, UK, and two email addresses, info@ and media@. There is no form or route for research partners, CROs, clinicians or patients.Source
  • 05

    The Institute of Computation is hiring two Director-level leaders, an ML scientist and a knowledge engineer, but it exists on the site only as a launch update. ML candidates compare Altos with AI labs and tech-bio startups that show their teams, problems and data.

    High impactLow effort First result in 1 month Talent acquisition lead

    First action

    Draft the IoC page with its leaders.

    How to measure it

    Qualified IoC applicants per role

    Now
    –
    Target
    +50%
    By
    90 days

    Steps

    1. 1

      Write the page

      Problems, data, team.

      Director / Senior Director, Machine Learning for Biology 1 week

    2. 2

      Add papers

      IoC publications.

      Communications lead 2 days

    3. 3

      Build

      Institute template.

      Web team 3 days

    4. 4

      Link roles

      Greenhouse by department.

      Web team 1 day

    5. 5

      Promote

      ML communities.

      Talent acquisition lead 2 weeks

    6. 6

      Measure

      Applicants by source.

      Talent acquisition lead monthly

    First result
    1 month
    Cost
    Staff time only
    Owner
    Talent acquisition lead

    Smallest test

    Publish the IoC page with open roles.

    Why it works

    Build an IoC page: the problems (multi-scale models of cell health, lab-in-the-loop), the data and infrastructure, team leaders, papers and open roles. Do the same for the Institutes of Science and the Institute of Medicine.

    Specific problems and data attract senior ML talent better than a mission statement.

    Risks and how to handle them

    • Disclosing too much

      Describe problems, not methods.

    Evidence

    • HiringInstitute of Computation hiring: a Director / Senior Director, Machine Learning for Biology ("Altos is asking questions biology has no method for yet"), a Director / Senior Director, Lab-in-the-Loop ("The rate limit on ML for biology is rarely the model. It is the loop between what the lab measures and what the model needs"), a Senior Scientist, Machine Learning, and a contract Senior Knowledge Engineer who will own "a large canonical LinkML/Biolink schema including REST/MCP/CLI service layer" and "an agentic / human-in-the-loop curation framework".Source
    • Your websiteAbout page: Altos "merges the best of academia and industry"; it is "developing multi-scale generative models to unravel the language of cell health" and is "generating a significant volume of high-quality data internally while also integrating external data sets"; the Institute of Computation complements "the Institutes of Science and the Institute of Medicine".Source
    • Your websiteSitemap (51 URLs, read October 22, 2026): home, about, science, careers, contact, FAQ, legal pages, four Featured items (newest last modified August 2025) and 39 team profiles. There is no page for publications, partnering, the institutes, or the pipeline.Source
    • Your websiteCareers page lists all 18 open Greenhouse postings, including three "General Interest: Join Our Talent Community" postings for Cambridge UK, San Diego and the Bay Area first published in 2022, with employee quotes on culture; jobs are not grouped by institute or discipline.Source
  • 06

    The careers page lists 18 postings in one list, three of them general "talent community" posts first published in 2022. Scientists look for their discipline and location first.

    Medium impactLow effort First result in 2 weeks Talent acquisition lead

    First action

    Group the list by department.

    How to measure it

    Talent sign-ups with discipline tag

    Now
    –
    Target
    300 a quarter
    By
    2 quarters

    Steps

    1. 1

      Group roles

      By institute and site.

      Web team 1 day

    2. 2

      New form

      Discipline and location.

      Talent acquisition lead 2 days

    3. 3

      Close old posts

      Three 2022 postings.

      Talent acquisition lead 1 hour

    4. 4

      How we hire

      Steps and timing.

      Talent acquisition lead 2 days

    5. 5

      Email pool

      When roles open.

      Talent acquisition lead ongoing

    6. 6

      Measure

      Hires from the pool.

      Talent acquisition lead quarterly

    First result
    2 weeks
    Cost
    $0
    Owner
    Talent acquisition lead

    Smallest test

    Group the list this week.

    Why it works

    Group openings by institute and site, replace the three old posts with one talent-community form that asks discipline and location, and add a short "how we hire" section.

    Easier navigation and a fresh talent pool help a hiring push in several locations.

    Risks and how to handle them

    • Losing old applicants

      Invite them to the new form.

    Evidence

    • Your websiteCareers page lists all 18 open Greenhouse postings, including three "General Interest: Join Our Talent Community" postings for Cambridge UK, San Diego and the Bay Area first published in 2022, with employee quotes on culture; jobs are not grouped by institute or discipline.Source
    • HiringCambridge, UK: a Manager / Senior Manager Genomics Hub (posted October 14, 2026) in the Institute of Technology will run RNAseq, ATACseq and single-cell genomics support and act as "a subject matter expert, consulting with researchers"; the board also lists open roles in the Bay Area and San Diego.Source
    • HiringInstitute of Computation hiring: a Director / Senior Director, Machine Learning for Biology ("Altos is asking questions biology has no method for yet"), a Director / Senior Director, Lab-in-the-Loop ("The rate limit on ML for biology is rarely the model. It is the loop between what the lab measures and what the model needs"), a Senior Scientist, Machine Learning, and a contract Senior Knowledge Engineer who will own "a large canonical LinkML/Biolink schema including REST/MCP/CLI service layer" and "an agentic / human-in-the-loop curation framework".Source

This quarter 9

The core plays for the next three months.

  • 07

    The alliances role must design "rigorous vetting frameworks" and review data against agreed quality standards. A scorecard turns that into a program CROs compete to join.

    High impactMedium effort First result in 1 quarter Senior Manager/Manager

    First action

    Score the last ten outsourced studies.

    How to measure it

    On-time, in-spec studies

    Now
    –
    Target
    90%
    By
    3 quarters

    Steps

    1. 1

      Define scores

      Five criteria.

      Senior Manager/Manager, CRO and KOL Alliances 2 weeks

    2. 2

      Back-score

      Past studies.

      Senior Manager/Manager, CRO and KOL Alliances 1 month

    3. 3

      Preferred list

      Per study type.

      Senior Manager/Manager, CRO and KOL Alliances 2 weeks

    4. 4

      Contract terms

      Faster for preferred.

      Business and Laboratory Operations Manager, 3DS 1 month

    5. 5

      Quarterly reviews

      With partners.

      Senior Manager/Manager, CRO and KOL Alliances quarterly

    6. 6

      Report

      To program leads.

      Senior Director, Project Team Leader quarterly

    First result
    1 quarter
    Cost
    Staff time only
    Owner
    Senior Manager/Manager, CRO and KOL Alliances

    Smallest test

    Score five CROs.

    Why it works

    Score each CRO on rigor, quality, turnaround, cost and data delivery after every study, keep a preferred list per study type, and give preferred partners faster contracting and forecasts of demand.

    Preferred status improves quality and price, and scores make selection faster and defensible.

    Risks and how to handle them

    • Partner lock-in

      Keep two per study type.

    Evidence

    • HiringSenior Manager/Manager, CRO and KOL Alliances (contract to hire, posted September 21, 2026, San Diego): will "lead the identification, qualification, and ongoing management of our external R&D ecosystem", "scouting, vetting, and managing top-tier Contract Research Organizations (CROs) and Key Opinion Leaders (KOLs) across global biopharma, academia, and specialized research institutes", "securing and overseeing a significant outsourced research program", and "Lead the onboarding, governance, and strategic direction of KOL networks" across "translational, clinical, and regulatory pathways".Source
    • HiringThe same role names where outsourcing adds value ("large-animal models, disease model optimization, GLP/non-GLP studies"), asks for "rigorous vetting frameworks for CROs" (scientific rigor, quality, capacity, turnaround times, compliance such as GCP, GLP, IACUC and IP protection), and study designs with "clear go/no-go criteria".Source
    • HiringDevelopment hiring: a Senior Director, Project Team Leader will lead teams "from preclinical proof-of-concept through clinical trials and regulatory filing"; a Scientist II, In Vivo Translational Sciences will "Develop, characterize, and implement new animal models; including models of fibrosis and other age-related pathologies"; a Business and Laboratory Operations Manager will run contract workflows with external vendors.Source
  • 08

    The alliances role will lead "the onboarding, governance, and strategic direction of KOL networks" across translational, clinical and regulatory pathways, and the Dorian programs and new fibrosis models point to fibrosis and age-related disease. Early, organized expert input shortens development.

    High impactMedium effort First result in 2 quarters Chief Medical Officer and Hea…

    First action

    Map opinion leaders for one indication.

    How to measure it

    KOL advisory sessions

    Now
    –
    Target
    4 a year per indication
    By
    1 year

    Steps

    1. 1

      Pick indications

      With program leads.

      Chief Medical Officer and Head of Product Development 2 weeks

    2. 2

      Map KOLs

      Publications and trials.

      Senior Manager/Manager, CRO and KOL Alliances 1 month

    3. 3

      Contracts

      Advisory terms.

      Deputy General Counsel and VP, Intellectual Property 1 month

    4. 4

      First board

      Endpoints and design.

      Chief Medical Officer and Head of Product Development 1 quarter

    5. 5

      Track input

      Decision log.

      Senior Director, Project Team Leader ongoing

    6. 6

      Review

      Yearly.

      Chief Medical Officer and Head of Product Development yearly

    First result
    2 quarters
    Cost
    Advisory fees
    Owner
    Chief Medical Officer and Head of Product Development

    Smallest test

    Hold one advisory call.

    Why it works

    Map ten to fifteen opinion leaders per candidate indication, set up advisory boards with clear contracts and conflict rules, hold quarterly sessions on endpoints and trial design, and track their input in decisions.

    Early expert input avoids costly design changes and builds future trial investigators.

    Risks and how to handle them

    • Conflicts of interest

      Disclose and cap engagements.

    Evidence

    • HiringSenior Manager/Manager, CRO and KOL Alliances (contract to hire, posted September 21, 2026, San Diego): will "lead the identification, qualification, and ongoing management of our external R&D ecosystem", "scouting, vetting, and managing top-tier Contract Research Organizations (CROs) and Key Opinion Leaders (KOLs) across global biopharma, academia, and specialized research institutes", "securing and overseeing a significant outsourced research program", and "Lead the onboarding, governance, and strategic direction of KOL networks" across "translational, clinical, and regulatory pathways".Source
    • HiringDevelopment hiring: a Senior Director, Project Team Leader will lead teams "from preclinical proof-of-concept through clinical trials and regulatory filing"; a Scientist II, In Vivo Translational Sciences will "Develop, characterize, and implement new animal models; including models of fibrosis and other age-related pathologies"; a Business and Laboratory Operations Manager will run contract workflows with external vendors.Source
    • News coverageIn May 2025 Altos acquired Dorian Therapeutics, a Stanford spinout developing small-molecule "senoblockers", with preclinical programs in lung fibrosis and osteoarthritis. The acquisition does not appear on altoslabs.com.Source
  • 09

    Altos merges academia and industry and has sites in three research hubs. Seminars draw the scientists, opinion leaders and candidates the company wants to meet.

    High impactMedium effort First result in 2 quarters Communications lead

    First action

    Plan the first seminar in Cambridge.

    How to measure it

    Seminar sign-ups

    Now
    –
    Target
    100 a quarter
    By
    2 quarters

    Steps

    1. 1

      Plan topics

      Science leads.

      Communications lead 2 weeks

    2. 2

      Book speakers

      Internal and external.

      Communications lead 1 month

    3. 3

      Invite

      Local universities.

      Communications lead 2 weeks

    4. 4

      Record

      Publish talks.

      Web team quarterly

    5. 5

      Capture

      Talent and partner sign-ups.

      Talent acquisition lead ongoing

    6. 6

      Review

      Attendance and hires.

      Communications lead quarterly

    First result
    2 quarters
    Cost
    Event costs
    Owner
    Communications lead

    Smallest test

    Host one seminar.

    Why it works

    Host a quarterly seminar at each site with an Altos scientist and an outside speaker, open to local academics; record talks for the site and invite attendees to the talent community and partnering page.

    Events build reputation and relationships in each hub, and recordings become content.

    Risks and how to handle them

    • Disclosure

      Review talks for unpublished data.

    Evidence

    • Your websiteAbout page: Altos "merges the best of academia and industry"; it is "developing multi-scale generative models to unravel the language of cell health" and is "generating a significant volume of high-quality data internally while also integrating external data sets"; the Institute of Computation complements "the Institutes of Science and the Institute of Medicine".Source
    • HiringCambridge, UK: a Manager / Senior Manager Genomics Hub (posted October 14, 2026) in the Institute of Technology will run RNAseq, ATACseq and single-cell genomics support and act as "a subject matter expert, consulting with researchers"; the board also lists open roles in the Bay Area and San Diego.Source
    • HiringSenior Manager/Manager, CRO and KOL Alliances (contract to hire, posted September 21, 2026, San Diego): will "lead the identification, qualification, and ongoing management of our external R&D ecosystem", "scouting, vetting, and managing top-tier Contract Research Organizations (CROs) and Key Opinion Leaders (KOLs) across global biopharma, academia, and specialized research institutes", "securing and overseeing a significant outsourced research program", and "Lead the onboarding, governance, and strategic direction of KOL networks" across "translational, clinical, and regulatory pathways".Source
    • Your websiteSitemap (51 URLs, read October 22, 2026): home, about, science, careers, contact, FAQ, legal pages, four Featured items (newest last modified August 2025) and 39 team profiles. There is no page for publications, partnering, the institutes, or the pipeline.Source
  • 10

    The Lab-in-the-Loop leader is hired because the bottleneck is "the loop between what the lab measures and what the model needs", while the alliances manager builds the outsourced network. Some standard assays can run outside to free internal labs for novel work.

    High impactHigh effort First result in 2 quarters Director / Senior Director

    First action

    List assays in the loop and their cycle times.

    How to measure it

    Loop cycle time

    Now
    –
    Target
    -30%
    By
    3 quarters

    Steps

    1. 1

      Map the loop

      Assays and times.

      Director / Senior Director, Lab-in-the-Loop 1 month

    2. 2

      Pick assays

      Standard, scalable.

      Director / Senior Director, Lab-in-the-Loop 2 weeks

    3. 3

      Data spec

      Schema-aligned.

      Senior Knowledge Engineer, Ontology and Data Standards 1 month

    4. 4

      Select CROs

      From the scorecard.

      Senior Manager/Manager, CRO and KOL Alliances 1 month

    5. 5

      Pilot

      One assay.

      Director / Senior Director, Lab-in-the-Loop 1 quarter

    6. 6

      Measure

      Cycle time and quality.

      Director / Senior Director, Lab-in-the-Loop monthly

    First result
    2 quarters
    Cost
    CRO study costs
    Owner
    Director / Senior Director, Lab in the Loop

    Smallest test

    Outsource one assay batch.

    Why it works

    Identify standardized assays in the loop that CROs can run at scale with tight data specifications, agree data formats through the canonical schema, and measure cycle time from prediction to result.

    A faster loop improves models sooner, and outsourcing routine work scales data without new lab space.

    Risks and how to handle them

    • Data quality drift

      Run internal controls in every batch.

    Evidence

    • HiringInstitute of Computation hiring: a Director / Senior Director, Machine Learning for Biology ("Altos is asking questions biology has no method for yet"), a Director / Senior Director, Lab-in-the-Loop ("The rate limit on ML for biology is rarely the model. It is the loop between what the lab measures and what the model needs"), a Senior Scientist, Machine Learning, and a contract Senior Knowledge Engineer who will own "a large canonical LinkML/Biolink schema including REST/MCP/CLI service layer" and "an agentic / human-in-the-loop curation framework".Source
    • HiringSenior Manager/Manager, CRO and KOL Alliances (contract to hire, posted September 21, 2026, San Diego): will "lead the identification, qualification, and ongoing management of our external R&D ecosystem", "scouting, vetting, and managing top-tier Contract Research Organizations (CROs) and Key Opinion Leaders (KOLs) across global biopharma, academia, and specialized research institutes", "securing and overseeing a significant outsourced research program", and "Lead the onboarding, governance, and strategic direction of KOL networks" across "translational, clinical, and regulatory pathways".Source
    • HiringThe same role names where outsourcing adds value ("large-animal models, disease model optimization, GLP/non-GLP studies"), asks for "rigorous vetting frameworks for CROs" (scientific rigor, quality, capacity, turnaround times, compliance such as GCP, GLP, IACUC and IP protection), and study designs with "clear go/no-go criteria".Source
  • 11

    The new IP leaders will "capture company inventions" and protect AI and biology inventions, while scientists recruited from academia expect to publish. Slow review frustrates both.

    High impactMedium effort First result in 1 quarter Deputy General Counsel and VP

    First action

    Measure today's review times.

    How to measure it

    Publication review time

    Now
    –
    Target
    10 working days
    By
    2 quarters

    Steps

    1. 1

      Measure

      Current reviews.

      Deputy General Counsel and VP, Intellectual Property 2 weeks

    2. 2

      Design process

      Form and turnaround.

      Deputy General Counsel and VP, Intellectual Property 1 month

    3. 3

      Train

      Scientists.

      Deputy General Counsel and VP, Intellectual Property 1 month

    4. 4

      Run

      All papers and talks.

      Deputy General Counsel and VP, Intellectual Property ongoing

    5. 5

      Track

      Times and filings.

      Deputy General Counsel and VP, Intellectual Property monthly

    6. 6

      Review

      Quarterly.

      Deputy General Counsel and VP, Intellectual Property quarterly

    First result
    1 quarter
    Cost
    Staff time only
    Owner
    Deputy General Counsel and VP, Intellectual Property

    Smallest test

    Run the process for one paper.

    Why it works

    Set a publication and talk review with a fixed turnaround (for example 10 working days), a disclosure form tied to the review, and a filing plan for priority inventions before submission.

    Predictable reviews protect IP and keep publishing, which helps recruiting and retention.

    Risks and how to handle them

    • Rushed filings

      Plan filings with program leads.

    Evidence

    • HiringIP hiring: a Deputy General Counsel and Vice President, Intellectual Property (posted October 6, 2026) to protect "groundbreaking innovations in cellular programming and computational biology" and "AI related inventions" and to "Drive initiatives to capture company inventions"; and a Senior Patent Counsel / Director, Intellectual Property (posted October 8, 2026).Source
    • News coverage"Inhibition of mesenchymal drift as a strategy for rejuvenation", published in Cell in 2025, was described by Genetic Engineering & Biotechnology News as one of the first major peer-reviewed reports from Altos Labs investigators; it reports widespread upregulation of mesenchymal genes across human tissues with age and disease. The site has no list of Altos papers.Source
    • Your websiteAbout page: Altos "merges the best of academia and industry"; it is "developing multi-scale generative models to unravel the language of cell health" and is "generating a significant volume of high-quality data internally while also integrating external data sets"; the Institute of Computation complements "the Institutes of Science and the Institute of Medicine".Source
  • 12

    Altos is hiring a Genomics Hub lead in Cambridge, UK, but the contact page gives only a phone number there, and no page describes the UK institute.

    Medium impactLow effort First result in 1 month Manager / Senior Manager Geno…

    First action

    Add the Cambridge address to the contact page.

    How to measure it

    Applicants for Cambridge roles

    Now
    –
    Target
    +30%
    By
    2 quarters

    Steps

    1. 1

      Add address

      Contact page.

      Web team 1 hour

    2. 2

      Write page

      Focus and team.

      Manager / Senior Manager Genomics Hub 2 weeks

    3. 3

      Photos

      Labs and people.

      Communications lead 2 weeks

    4. 4

      Publish

      Footer link.

      Web team 1 day

    5. 5

      Promote

      UK networks.

      Talent acquisition lead 1 month

    6. 6

      Measure

      UK applicants.

      Talent acquisition lead quarterly

    First result
    1 month
    Cost
    Photography
    Owner
    Manager / Senior Manager Genomics Hub

    Smallest test

    Add the address today.

    Why it works

    Add a Cambridge page: the institute's focus, the Genomics Hub, the team, local collaborations, address and open roles, and list it in the footer.

    UK candidates and partners need to see that Altos has a real research presence there.

    Risks and how to handle them

    • Site security

      Avoid detailed lab layouts.

    Evidence

    • HiringCambridge, UK: a Manager / Senior Manager Genomics Hub (posted October 14, 2026) in the Institute of Technology will run RNAseq, ATACseq and single-cell genomics support and act as "a subject matter expert, consulting with researchers"; the board also lists open roles in the Bay Area and San Diego.Source
    • Your websiteContact page: a street address for the Bay Area site only, phone numbers for San Diego and Cambridge, UK, and two email addresses, info@ and media@. There is no form or route for research partners, CROs, clinicians or patients.Source
    • Your websiteSitemap (51 URLs, read October 22, 2026): home, about, science, careers, contact, FAQ, legal pages, four Featured items (newest last modified August 2025) and 39 team profiles. There is no page for publications, partnering, the institutes, or the pipeline.Source
  • 13

    Altos has LinkedIn and X accounts but the site shows little recent activity. Scientists and engineers follow people more than companies.

    Medium impactLow effort First result in 1 quarter Communications lead

    First action

    Recruit five scientist volunteers.

    How to measure it

    Applicants citing social

    Now
    –
    Target
    10%
    By
    2 quarters

    Steps

    1. 1

      Volunteers

      Ten scientists.

      Communications lead 2 weeks

    2. 2

      Guidelines

      What can be shared.

      Deputy General Counsel and VP, Intellectual Property 1 week

    3. 3

      Support

      Drafts and visuals.

      Communications lead monthly

    4. 4

      Amplify

      Company accounts.

      Communications lead ongoing

    5. 5

      Track

      Reach and applicants.

      Talent acquisition lead monthly

    6. 6

      Review

      Quarterly.

      Communications lead quarterly

    First result
    1 quarter
    Cost
    Staff time only
    Owner
    Communications lead

    Smallest test

    Publish one post about the Cell paper.

    Why it works

    Support ten scientists to post monthly about papers, methods and talks, with communications help and review, and share their posts from company accounts.

    Personal voices build credibility and reach candidates directly.

    Risks and how to handle them

    • Unreviewed disclosures

      Light review before posting.

    Evidence

    • Your websiteThe Featured page carries no dates. Its items are the appointment of Joan Mannick, M.D., as Chief Medical Officer and Head of Product Development, the launch of the Institute of Computation, a BBVA Frontiers of Knowledge Award to a Distinguished Investigator, and older media pieces (Inverse, The Economist, Endpoints News) about the company's launch.Source
    • News coverage"Inhibition of mesenchymal drift as a strategy for rejuvenation", published in Cell in 2025, was described by Genetic Engineering & Biotechnology News as one of the first major peer-reviewed reports from Altos Labs investigators; it reports widespread upregulation of mesenchymal genes across human tissues with age and disease. The site has no list of Altos papers.Source
    • HiringInstitute of Computation hiring: a Director / Senior Director, Machine Learning for Biology ("Altos is asking questions biology has no method for yet"), a Director / Senior Director, Lab-in-the-Loop ("The rate limit on ML for biology is rarely the model. It is the loop between what the lab measures and what the model needs"), a Senior Scientist, Machine Learning, and a contract Senior Knowledge Engineer who will own "a large canonical LinkML/Biolink schema including REST/MCP/CLI service layer" and "an agentic / human-in-the-loop curation framework".Source
  • 14

    Real visitors pass Core Web Vitals, but the mobile lab test takes 8.4 seconds to show the mission image and 5.8 seconds for the first paint, and candidates often open the site on a phone from a job post.

    Low impactLow effort First result in 2 weeks Web team

    First action

    Compress the mission image.

    How to measure it

    Mobile LCP

    Now
    –
    Target
    under 3 s
    By
    30 days

    Steps

    1. 1

      Profile

      PageSpeed.

      Web team 1 hour

    2. 2

      Poster image

      Before video.

      Web team 1 day

    3. 3

      Compress

      Mission image.

      Web team 1 hour

    4. 4

      Lazy load

      Below the fold.

      Web team 1 day

    5. 5

      Retest

      Lab and field.

      Web team 1 day

    6. 6

      Monitor

      Monthly.

      Web team monthly

    First result
    2 weeks
    Cost
    $0
    Owner
    Web team

    Smallest test

    Swap in a poster image.

    Why it works

    Serve a smaller poster image first, load the video after, and compress the mission image.

    A faster first view keeps mobile visitors from job boards on the page.

    Risks and how to handle them

    • Visual quality

      Check on large screens.

    Evidence

    • Google PageSpeedHomepage, mobile lab test: performance 60, Largest Contentful Paint 8.4 s (the mission image), first paint 5.8 s; desktop performance 87. Real Chrome visitors pass Core Web Vitals (LCP about 1.5 s on the page and 2.2 s across the site at the 75th percentile, INP 85 ms, CLS 0).Source
  • 15

    The 3DS operations manager will manage contract and SOW workflows with Legal, Procurement and vendors, and the alliances role will award many CRO studies. Slow contracting delays studies.

    Medium impactMedium effort First result in 1 quarter Business and Laboratory Opera…

    First action

    Measure time from CRO selection to signed SOW.

    How to measure it

    Selection to signed SOW

    Now
    –
    Target
    -40%
    By
    2 quarters

    Steps

    1. 1

      Measure

      Current cycle.

      Business and Laboratory Operations Manager, 3DS 2 weeks

    2. 2

      Templates

      CDA, MSA, SOW.

      Deputy General Counsel and VP, Intellectual Property 1 month

    3. 3

      Fallbacks

      Pre-approved terms.

      Deputy General Counsel and VP, Intellectual Property 1 month

    4. 4

      Tracker

      Shared.

      Business and Laboratory Operations Manager, 3DS 2 weeks

    5. 5

      Review

      Monthly.

      Business and Laboratory Operations Manager, 3DS monthly

    6. 6

      Report

      To leadership.

      Senior Director, Project Team Leader quarterly

    First result
    1 quarter
    Cost
    Staff time only
    Owner
    Business and Laboratory Operations Manager, 3DS

    Smallest test

    Use the new SOW template once.

    Why it works

    Create standard CDA, MSA and SOW templates with pre-approved fallback terms, a shared tracker with target times per step, and a monthly review of bottlenecks.

    Shorter contracting means earlier data and better partner relationships.

    Risks and how to handle them

    • Weaker terms

      Keep IP terms fixed.

    Evidence

    • HiringDevelopment hiring: a Senior Director, Project Team Leader will lead teams "from preclinical proof-of-concept through clinical trials and regulatory filing"; a Scientist II, In Vivo Translational Sciences will "Develop, characterize, and implement new animal models; including models of fibrosis and other age-related pathologies"; a Business and Laboratory Operations Manager will run contract workflows with external vendors.Source
    • HiringSenior Manager/Manager, CRO and KOL Alliances (contract to hire, posted September 21, 2026, San Diego): will "lead the identification, qualification, and ongoing management of our external R&D ecosystem", "scouting, vetting, and managing top-tier Contract Research Organizations (CROs) and Key Opinion Leaders (KOLs) across global biopharma, academia, and specialized research institutes", "securing and overseeing a significant outsourced research program", and "Lead the onboarding, governance, and strategic direction of KOL networks" across "translational, clinical, and regulatory pathways".Source
    • HiringIP hiring: a Deputy General Counsel and Vice President, Intellectual Property (posted October 6, 2026) to protect "groundbreaking innovations in cellular programming and computational biology" and "AI related inventions" and to "Drive initiatives to capture company inventions"; and a Senior Patent Counsel / Director, Intellectual Property (posted October 8, 2026).Source

Big bets 3

Larger plays that can change the trajectory.

  • 16

    Altos appointed a Chief Medical Officer and Head of Product Development and is hiring a project leader for work "through clinical trials and regulatory filing". Investigators and sites take time to recruit.

    High impactHigh effort First result in 4 quarters Chief Medical Officer and Hea…

    First action

    List candidate sites for one indication.

    How to measure it

    Qualified sites

    Now
    –
    Target
    10 per indication
    By
    4 quarters

    Steps

    1. 1

      Indications

      Program leads.

      Chief Medical Officer and Head of Product Development 1 month

    2. 2

      Investigators

      From KOL map.

      Senior Manager/Manager, CRO and KOL Alliances 1 quarter

    3. 3

      Feasibility

      With a CRO.

      Senior Manager/Manager, CRO and KOL Alliances 1 quarter

    4. 4

      Advocacy

      Patient groups.

      Chief Medical Officer and Head of Product Development 1 quarter

    5. 5

      Site agreements

      Templates.

      Business and Laboratory Operations Manager, 3DS 1 quarter

    6. 6

      Review

      Readiness.

      Senior Director, Project Team Leader quarterly

    First result
    4 quarters
    Cost
    Feasibility costs
    Owner
    Chief Medical Officer and Head of Product Development

    Smallest test

    Run feasibility for one indication.

    Why it works

    Turn the KOL network into a shortlist of investigators and sites per indication, run feasibility with a CRO, and prepare patient-advocacy contacts, so the network is ready when a program reaches the clinic.

    Prepared sites cut startup time, which is often the longest delay in early trials.

    Risks and how to handle them

    • Programs change

      Keep the network broad within each therapeutic area.

    Evidence

    • HiringDevelopment hiring: a Senior Director, Project Team Leader will lead teams "from preclinical proof-of-concept through clinical trials and regulatory filing"; a Scientist II, In Vivo Translational Sciences will "Develop, characterize, and implement new animal models; including models of fibrosis and other age-related pathologies"; a Business and Laboratory Operations Manager will run contract workflows with external vendors.Source
    • Your websiteThe Featured page carries no dates. Its items are the appointment of Joan Mannick, M.D., as Chief Medical Officer and Head of Product Development, the launch of the Institute of Computation, a BBVA Frontiers of Knowledge Award to a Distinguished Investigator, and older media pieces (Inverse, The Economist, Endpoints News) about the company's launch.Source
    • HiringSenior Manager/Manager, CRO and KOL Alliances (contract to hire, posted September 21, 2026, San Diego): will "lead the identification, qualification, and ongoing management of our external R&D ecosystem", "scouting, vetting, and managing top-tier Contract Research Organizations (CROs) and Key Opinion Leaders (KOLs) across global biopharma, academia, and specialized research institutes", "securing and overseeing a significant outsourced research program", and "Lead the onboarding, governance, and strategic direction of KOL networks" across "translational, clinical, and regulatory pathways".Source
  • 17

    Altos acquired Dorian's small-molecule senoblocker programs in lung fibrosis and osteoarthritis, alongside its rejuvenation work. A company focused on cell rejuvenation may not develop every asset itself.

    High impactHigh effort First result in 4 quarters Senior Director

    First action

    Rank programs by fit with the core mission.

    How to measure it

    Partner term sheets

    Now
    –
    Target
    1
    By
    4 quarters

    Steps

    1. 1

      Portfolio review

      Core or not.

      Senior Director, Project Team Leader 1 quarter

    2. 2

      Data package

      For partners.

      Senior Director, Project Team Leader 1 quarter

    3. 3

      IP check

      Freedom to operate.

      Deputy General Counsel and VP, Intellectual Property 1 month

    4. 4

      Outreach

      Pharma BD.

      Senior Manager/Manager, CRO and KOL Alliances 1 quarter

    5. 5

      Negotiate

      Terms.

      Senior Director, Project Team Leader 1 quarter

    6. 6

      Decide

      Leadership.

      Chief Medical Officer and Head of Product Development 1 month

    First result
    4 quarters
    Cost
    BD time
    Owner
    Senior Director, Project Team Leader

    Smallest test

    Prepare a non-confidential summary for one program.

    Why it works

    Review which programs are core, and for the rest consider co-development or licensing with pharma partners that have fibrosis or musculoskeletal franchises, keeping rights to the core platform.

    Partnering brings outside money and expertise, and keeps internal teams focused.

    Risks and how to handle them

    • Selling too early

      Partner after a clear data milestone.

    Evidence

    • News coverageIn May 2025 Altos acquired Dorian Therapeutics, a Stanford spinout developing small-molecule "senoblockers", with preclinical programs in lung fibrosis and osteoarthritis. The acquisition does not appear on altoslabs.com.Source
    • HiringDevelopment hiring: a Senior Director, Project Team Leader will lead teams "from preclinical proof-of-concept through clinical trials and regulatory filing"; a Scientist II, In Vivo Translational Sciences will "Develop, characterize, and implement new animal models; including models of fibrosis and other age-related pathologies"; a Business and Laboratory Operations Manager will run contract workflows with external vendors.Source
    • HiringIP hiring: a Deputy General Counsel and Vice President, Intellectual Property (posted October 6, 2026) to protect "groundbreaking innovations in cellular programming and computational biology" and "AI related inventions" and to "Drive initiatives to capture company inventions"; and a Senior Patent Counsel / Director, Intellectual Property (posted October 8, 2026).Source
  • 18

    Altos generates large internal datasets and has built a canonical biology schema with an MCP service layer. Open benchmarks are how AI labs earn reputation and attract talent.

    High impactHigh effort First result in 4 quarters Senior Knowledge Engineer

    First action

    Shortlist three non-core datasets.

    How to measure it

    Teams submitting results

    Now
    –
    Target
    50
    By
    1 year

    Steps

    1. 1

      Pick data

      Non-core.

      Director / Senior Director, Machine Learning for Biology 1 month

    2. 2

      IP review

      License terms.

      Deputy General Counsel and VP, Intellectual Property 1 month

    3. 3

      Prepare

      Schema-aligned release.

      Senior Knowledge Engineer, Ontology and Data Standards 1 quarter

    4. 4

      Baselines

      Models and code.

      Director / Senior Director, Machine Learning for Biology 1 quarter

    5. 5

      Launch

      Paper and leaderboard.

      Communications lead 1 month

    6. 6

      Engage

      Workshops.

      Director / Senior Director, Machine Learning for Biology ongoing

    First result
    4 quarters
    Cost
    Engineering time
    Owner
    Senior Knowledge Engineer, Ontology and Data Standards

    Smallest test

    Release a small benchmark first.

    Why it works

    Pick one non-core dataset or task (for example cell-state prediction), release it with a benchmark and baseline models under a research license, and host a leaderboard.

    Benchmarks draw the ML community to Altos's problems and give recruiters a calling card.

    Risks and how to handle them

    • Giving away value

      Release only non-core data.

    Evidence

    • HiringInstitute of Computation hiring: a Director / Senior Director, Machine Learning for Biology ("Altos is asking questions biology has no method for yet"), a Director / Senior Director, Lab-in-the-Loop ("The rate limit on ML for biology is rarely the model. It is the loop between what the lab measures and what the model needs"), a Senior Scientist, Machine Learning, and a contract Senior Knowledge Engineer who will own "a large canonical LinkML/Biolink schema including REST/MCP/CLI service layer" and "an agentic / human-in-the-loop curation framework".Source
    • Your websiteAbout page: Altos "merges the best of academia and industry"; it is "developing multi-scale generative models to unravel the language of cell health" and is "generating a significant volume of high-quality data internally while also integrating external data sets"; the Institute of Computation complements "the Institutes of Science and the Institute of Medicine".Source
    • HiringIP hiring: a Deputy General Counsel and Vice President, Intellectual Property (posted October 6, 2026) to protect "groundbreaking innovations in cellular programming and computational biology" and "AI related inventions" and to "Drive initiatives to capture company inventions"; and a Senior Patent Counsel / Director, Intellectual Property (posted October 8, 2026).Source

Wildcards 3

Unexpected experiments, each with a cheap way to test it.

  • 19

    The science page tells the story from Yamanaka to partial reprogramming, but the public, patients and many candidates need simple explanations, and hype about longevity is everywhere.

    Medium impactLow effort First result in 1 quarter Communications lead

    First action

    Write one explainer on mesenchymal drift.

    How to measure it

    Monthly readers

    Now
    –
    Target
    5,000
    By
    2 quarters

    Steps

    1. 1

      Pick topics

      Five.

      Communications lead 1 week

    2. 2

      Write

      With scientists.

      Communications lead 1 month

    3. 3

      Review

      Scientific and legal.

      Deputy General Counsel and VP, Intellectual Property 2 weeks

    4. 4

      Publish

      Science section.

      Web team 1 week

    5. 5

      Share

      Social.

      Communications lead ongoing

    6. 6

      Update

      Yearly.

      Communications lead yearly

    First result
    1 quarter
    Cost
    Writing time
    Owner
    Communications lead

    Smallest test

    Publish one explainer.

    Why it works

    Publish short, careful explainers (what partial reprogramming is, what mesenchymal drift means, what is known and unknown) with references, reviewed by Altos scientists.

    Accurate public explainers build trust and set Altos apart from hype.

    Risks and how to handle them

    • Over-promising

      State what is unknown.

    Evidence

    • News coverage"Inhibition of mesenchymal drift as a strategy for rejuvenation", published in Cell in 2025, was described by Genetic Engineering & Biotechnology News as one of the first major peer-reviewed reports from Altos Labs investigators; it reports widespread upregulation of mesenchymal genes across human tissues with age and disease. The site has no list of Altos papers.Source
    • Your websiteAbout page: Altos "merges the best of academia and industry"; it is "developing multi-scale generative models to unravel the language of cell health" and is "generating a significant volume of high-quality data internally while also integrating external data sets"; the Institute of Computation complements "the Institutes of Science and the Institute of Medicine".Source
    • Competitor researchPeers' own sites: Calico links to /publications and /partnering pages; Life Biosciences has a publications page and a pipeline page; NewLimit is "extending human healthspan by unlocking regenerative potential"; Retro Biosciences "develops therapies that target aging biology to extend healthy human lifespan by 10 years".Source
  • 20

    The careers page quotes employees but shows no work. Candidates in ML, in vivo pharmacology and genomics want to see the work and the people.

    Medium impactLow effort First result in 1 quarter Talent acquisition lead

    First action

    Film the first video with the Genomics Hub.

    How to measure it

    Applications per role

    Now
    –
    Target
    +25%
    By
    2 quarters

    Steps

    1. 1

      Pick people

      Three disciplines.

      Talent acquisition lead 2 weeks

    2. 2

      Script

      One problem each.

      Communications lead 1 week

    3. 3

      Film

      In the labs.

      Communications lead 1 month

    4. 4

      Review

      Disclosure.

      Deputy General Counsel and VP, Intellectual Property 1 week

    5. 5

      Publish

      Job posts and careers.

      Web team 1 week

    6. 6

      Measure

      Applications.

      Talent acquisition lead monthly

    First result
    1 quarter
    Cost
    Video costs
    Owner
    Talent acquisition lead

    Smallest test

    Record one video on a phone.

    Why it works

    Film two-minute videos with a scientist from each discipline (the IoC, in vivo, Genomics Hub) about a real problem they work on, and add them to the job posts.

    Seeing the work and the team raises applications from the right people.

    Risks and how to handle them

    • Lab confidentiality

      Film in public areas.

    Evidence

    • Your websiteCareers page lists all 18 open Greenhouse postings, including three "General Interest: Join Our Talent Community" postings for Cambridge UK, San Diego and the Bay Area first published in 2022, with employee quotes on culture; jobs are not grouped by institute or discipline.Source
    • HiringInstitute of Computation hiring: a Director / Senior Director, Machine Learning for Biology ("Altos is asking questions biology has no method for yet"), a Director / Senior Director, Lab-in-the-Loop ("The rate limit on ML for biology is rarely the model. It is the loop between what the lab measures and what the model needs"), a Senior Scientist, Machine Learning, and a contract Senior Knowledge Engineer who will own "a large canonical LinkML/Biolink schema including REST/MCP/CLI service layer" and "an agentic / human-in-the-loop curation framework".Source
    • HiringCambridge, UK: a Manager / Senior Manager Genomics Hub (posted October 14, 2026) in the Institute of Technology will run RNAseq, ATACseq and single-cell genomics support and act as "a subject matter expert, consulting with researchers"; the board also lists open roles in the Bay Area and San Diego.Source
  • 21

    Once the alliances program is running, the best CROs and academic partners should meet Altos scientists together, hear priorities and propose ideas.

    Medium impactLow effort First result in 1 quarter Senior Manager/Manager

    First action

    Invite the top ten CROs.

    How to measure it

    New partner proposals

    Now
    –
    Target
    20
    By
    1 year

    Steps

    1. 1

      Plan

      Agenda.

      Senior Manager/Manager, CRO and KOL Alliances 1 month

    2. 2

      Invite

      Top partners.

      Senior Manager/Manager, CRO and KOL Alliances 1 month

    3. 3

      Prepare

      Non-confidential needs.

      Senior Director, Project Team Leader 1 month

    4. 4

      Host

      One day.

      Senior Manager/Manager, CRO and KOL Alliances 1 day

    5. 5

      Follow up

      Proposals.

      Senior Manager/Manager, CRO and KOL Alliances 1 month

    6. 6

      Review

      Results.

      Senior Manager/Manager, CRO and KOL Alliances yearly

    First result
    1 quarter
    Cost
    Event cost
    Owner
    Senior Manager/Manager, CRO and KOL Alliances

    Smallest test

    Host a virtual partner hour.

    Why it works

    Hold a yearly partner day: Altos shares non-confidential priorities and study needs, CROs present new capabilities, and the best partners are recognized.

    Shared priorities lead to better proposals and stronger partner loyalty.

    Risks and how to handle them

    • Confidentiality

      Share only public priorities.

    Evidence

    • HiringSenior Manager/Manager, CRO and KOL Alliances (contract to hire, posted September 21, 2026, San Diego): will "lead the identification, qualification, and ongoing management of our external R&D ecosystem", "scouting, vetting, and managing top-tier Contract Research Organizations (CROs) and Key Opinion Leaders (KOLs) across global biopharma, academia, and specialized research institutes", "securing and overseeing a significant outsourced research program", and "Lead the onboarding, governance, and strategic direction of KOL networks" across "translational, clinical, and regulatory pathways".Source
    • HiringThe same role names where outsourcing adds value ("large-animal models, disease model optimization, GLP/non-GLP studies"), asks for "rigorous vetting frameworks for CROs" (scientific rigor, quality, capacity, turnaround times, compliance such as GCP, GLP, IACUC and IP protection), and study designs with "clear go/no-go criteria".Source

03

How Programmable can help

Where an idea in this playbook is something Programmable builds or runs, it's listed here with what we'd do. Everything else is yours to run.

ProgrammableInfo

Turn the research into a list you can act on

These ideas start with finding the right companies. Info finds them and the right person at each, researches every one and drafts the outreach, then asks before it sends.

  • Build this list in Info for idea #5 (opens programmable.info in a new tab)

New accounts: 100,000 free credits with code BETA100K

Find the companies (opens programmable.info in a new tab)
ProgrammableDigital

Show it, don't just describe it

These ideas need something to show: a demo, a video, an animation, graphics or a deck. Digital turns screenshots or the site into all of them, in the company's own brand.

Make a demo (opens programmable.digital in a new tab)
More example playbooks and reviews

More growth playbooks

Other companies we have researched, each read from what they are hiring for.

  • Goodnotes growth strategyA note-taking app built around natural handwriting, with AI, PDF annotation, whiteboards, text documents, audio and real-time…21 growth ideas
  • Greenworks Tools growth strategyBattery-powered outdoor power equipment, pressure washers and power tools across 24V, 40V, 60V, 80V and commercial 82V platforms, sold…21 growth ideas
  • Elevated Ops growth strategyA founder-led operations and systems practice. It audits a service business's back office, builds the fixes (CRM, automations, databases…23 growth ideas
  • Antithesis growth strategyAn autonomous testing platform that runs whole software systems in a deterministic simulation, injects faults, finds bugs other testing…22 growth ideas
  • BioCentury growth strategyAn intelligence platform for biopharma: independent analysis and news, the BCIQ drug discovery and development database, executive and…22 growth ideas
  • Alan growth strategyA digital health insurer combining insurance, prevention and care: health and prévoyance plans, the Alan app with Mo (an AI medical…21 growth ideas
  • Airdog USA growth strategyDirect-to-consumer air purifiers with washable TPA electrostatic filtration (X1+, X3, X5, X5+, X8 and pet models), plus humidifiers, fans…21 growth ideas
  • Rune Technologies growth strategyDefense software for military logistics and sustainment: TyrOS, an AI-enabled, offline-first logistics command and control platform, with…20 growth ideas

See every playbook and website review

Independent research. Programmable wrote this playbook from public sources, as they stood on October 23, 2026, and cites them throughout. Altos Labs did not commission, review or endorse it, and Programmable is not affiliated with Altos Labs. Company and product names are trademarks of their owners, used only to identify them. The ideas are suggestions and opinion, not professional, legal or financial advice, and not statements about how Altos Labs runs its business.

Something wrong, or do you represent Altos Labs? Email [email protected] and we will correct it or take it down.

30/60/90 roadmap

What to focus on in each month, and the ideas that carry it.

  1. Days 1 to 306 ideas

    Partner page, publications, dated news and FAQ, the Institute of Computation page and a cleaner careers page.

  2. Days 31 to 6010 ideas

    CRO scorecard, KOL network, seminars, the outsourced lab-in-the-loop, IP review, the Cambridge page, scientist voices, page speed and faster contracting; lab videos.

  3. Days 61 to 905 ideas

    Commit to the investigator network, partnering non-core programs and an open benchmark; explainers and a partner day.

The research behind the plan

3 research areas, each summarised in a few lines. Open any of them for the full detail.

Customers

What customers say

Customers value A bold mission and deep science. The most cited problem: little public detail on progress.

  • Academic freedom with industry focus
  • Hard for partners to know how to engage
  • In their words: “cell rejuvenation”

Market

Competitive landscape

4 competitors compared: Calico, NewLimit, Retro Biosciences and Life Biosciences.

  • Gap to exploit: A clear partnering route in rejuvenation biotech
  • Calico: Slow public progress
  • NewLimit: Earlier stage

Hiring signals

Altos is hiring to move from discovery toward development and to scale its computational engine.

  • Senior Manager/Manager, CRO and KOL Alliances: An outsourced research network and KOL program. Ideas 1, 7, 8.
  • Director / Senior Director, Lab-in-the-Loop: Faster loop between lab and models. Idea 10.
  • Director / Senior Director, Machine Learning for Biology: Senior ML leadership. Ideas 5, 18.

From the team that wrote this playbook

All products
  • ProgrammableAgencyWorking AI systems in days, not quarters (opens programmable.agency in a new tab)
  • ProgrammableInfoAn agent that finds, researches and asks firstNew accounts get 100,000 free enrichment credits with code BETA100K (opens programmable.info in a new tab)
  • ProgrammableDigitalScreenshots in, an animated product demo out (opens programmable.digital in a new tab)
  • ProgrammableWatchKnow the day a supplier falls out of compliance (opens programmable.watch in a new tab)
  • ProgrammableTalkGet registrants for your events, and know who’s coming (opens programmable.talk in a new tab)
  • ProgrammableMediaAn AI note taker, interpreter and webinar host for your calls (opens programmable.media in a new tab)
  • ProgrammablePageText what you need, your customer gets a page that works (opens programmable.page in a new tab)
  • ProgrammableCommunityForums with labelled AI members, never empty (opens programmable.community in a new tab)
ProgrammableMarketing
ExamplesLeaderboardsProductsTermsPrivacyCookiesDPALegalContact

© 2026 AI-Powered Growth Intelligence